FDA Inspection 1119401 — Oximeter Plus, Inc

Oximeter Plus, Inc — FEI 3007176465

The FDA completed an inspection of Oximeter Plus, Inc on February 20, 2020 in Roslyn Heights, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Roslyn Heights, NY (United States)

Citations

IDCFRDescription
312821 CFR 820.90(a)Nonconforming product control
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements